These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 16709870)
1. The role of noradrenergic nerves in the development of the lymphoproliferative disease in Fas-deficient, lpr/lpr mice. del Rey A; Roggero E; Kabiersch A; Schäfer M; Besedovsky HO J Immunol; 2006 Jun; 176(11):7079-86. PubMed ID: 16709870 [TBL] [Abstract][Full Text] [Related]
2. The sympathetic nervous system modulates CD4(+)Foxp3(+) regulatory T cells via noradrenaline-dependent apoptosis in a murine model of lymphoproliferative disease. Wirth T; Westendorf AM; Bloemker D; Wildmann J; Engler H; Mollerus S; Wadwa M; Schäfer MK; Schedlowski M; del Rey A Brain Behav Immun; 2014 May; 38():100-10. PubMed ID: 24440144 [TBL] [Abstract][Full Text] [Related]
3. Sympathetic abnormalities during autoimmune processes: potential relevance of noradrenaline-induced apoptosis. Del Rey A; Kabiersch A; Petzoldt S; Besedovsky HO Ann N Y Acad Sci; 2003 May; 992():158-67. PubMed ID: 12794055 [TBL] [Abstract][Full Text] [Related]
4. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome. Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009 [TBL] [Abstract][Full Text] [Related]
5. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice. Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779 [TBL] [Abstract][Full Text] [Related]
6. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha. Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486 [TBL] [Abstract][Full Text] [Related]
7. Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL/6-lpr/lpr mice. Schneider E; Moreau G; Arnould A; Vasseur F; Khodabaccus N; Dy M; Ezine S Blood; 1999 Oct; 94(8):2613-21. PubMed ID: 10515865 [TBL] [Abstract][Full Text] [Related]
9. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261 [TBL] [Abstract][Full Text] [Related]
10. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice. Lenda DM; Stanley ER; Kelley VR J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612 [TBL] [Abstract][Full Text] [Related]
11. Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease. Do Y; Rafi-Janajreh AQ; McKallip RJ; Nagarkatti PS; Nagarkatti M Int Immunol; 2003 Nov; 15(11):1327-40. PubMed ID: 14565931 [TBL] [Abstract][Full Text] [Related]
12. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice. Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074 [TBL] [Abstract][Full Text] [Related]
13. Sympathetic nervous system-immune interactions in autoimmune lymphoproliferative diseases. del Rey A; Besedovsky HO Neuroimmunomodulation; 2008; 15(1):29-36. PubMed ID: 18667797 [TBL] [Abstract][Full Text] [Related]
14. Hypogammaglobulinaemia occurs in Fas-deficient MRL-lpr mice following deletion of MHC class II molecules. Anderson CC; Mukherjee R; Sinclair NR; Jevnikar AM Clin Exp Immunol; 1997 Sep; 109(3):473-9. PubMed ID: 9328125 [TBL] [Abstract][Full Text] [Related]
15. Aberrant expression and dysfunction of Fas antigen in MRL/MpJ-lpr/lpr murine ovary. Xu JP; Li X; Mori E; Guo MW; Mori T Zygote; 1998 Nov; 6(4):359-67. PubMed ID: 9921647 [TBL] [Abstract][Full Text] [Related]
16. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model. Omokaro SO; Desierto MJ; Eckhaus MA; Ellison FM; Chen J; Young NS J Immunol; 2009 Mar; 182(6):3414-22. PubMed ID: 19265119 [TBL] [Abstract][Full Text] [Related]
17. Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice. Yoshida T; Higuchi T; Hagiyama H; Strasser A; Nishioka K; Tsubata T Int Immunol; 2000 Apr; 12(4):517-26. PubMed ID: 10744653 [TBL] [Abstract][Full Text] [Related]
18. The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. Ford MS; Young KJ; Zhang Z; Ohashi PS; Zhang L J Exp Med; 2002 Jul; 196(2):261-7. PubMed ID: 12119351 [TBL] [Abstract][Full Text] [Related]
19. Rheumatic diseases in an MRL strain of mice with a deficit in the functional Fas ligand. Ito MR; Terasaki S; Itoh J; Katoh H; Yonehara S; Nose M Arthritis Rheum; 1997 Jun; 40(6):1054-63. PubMed ID: 9182916 [TBL] [Abstract][Full Text] [Related]
20. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Wu J; Zhou T; Zhang J; He J; Gause WC; Mountz JD Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2344-8. PubMed ID: 7510888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]